Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Filings indexed 2,023 across all filing types
Latest filing 2024-03-29 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
SRP 24 FR.pdf
Transaction in Own Shares Classification · 100% confidence The document is titled 'Programme de rachat d'actions propres 2024' (2024 Share Repurchase Program) and explicitly announces the launch of a share buyback program to cover employee long-term incentive plans. This directly relates to the company acquiring its own shares. The definition for 'Transaction in Own Shares' (POS) covers 'Report of the company buying back or selling its own shares (share repurchase/issuance)'. Although it is an announcement, the core subject matter is the transaction itself, making POS a more specific fit than the general 'Report Publication Announcement' (RPA) or 'Regulatory Filing' (RNS), especially given the detailed nature of the announcement regarding the purpose and maximum number of shares (1,300,000).
2024-03-29 French
SRP 2024 NL.pdf
Transaction in Own Shares Classification · 100% confidence The document is titled "Aandelen Inkoopprogramma 2024" (Share Buyback Program 2024) and explicitly announces the start of a share repurchase program ('aandelen inkoopprogramma'). It details the maximum number of shares to be repurchased (1,300,000) and the purpose (to cover employee incentive plans). This directly corresponds to the definition of a company buying back or selling its own shares, which is classified as 'Transaction in Own Shares' (POS). The document is a formal announcement, not a full financial report or a general regulatory filing.
2024-03-29 Dutch
Proxy General Meeting 25 April 2024 - ENG - Final.pdf
Proxy Solicitation & Information Statement Classification · 100% confidence The document is explicitly titled "PROXY FOR THE GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON 25 APRIL 2024". It contains detailed instructions on how to appoint a proxy holder, lists the agenda items for the General Meeting (including approval of annual accounts, remuneration reports, director appointments, and auditor renewal), and provides voting checkboxes (FOR/AGAINST/ABSTAIN) for each resolution. This content is characteristic of proxy materials distributed to shareholders ahead of an Annual General Meeting (AGM) to solicit their votes. This aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI), although it is also closely related to AGM materials (AGM-R). Since it is the actual proxy form used to cast votes for the meeting, PSI is the most precise fit, as it solicits votes, whereas AGM-R often refers to the presentation materials used during the meeting itself. Given the structure, PSI is the primary classification.
2024-03-22 English
UCB SA_Board of Directors report_12_2023 FR - Final (web).pdf
Audit Report / Information Classification · 98% confidence The document is explicitly titled in French as "Rapport annuel du Conseil d'Administration pour l'exercice social se clôturant le 31 décembre 2023" (Annual Report of the Board of Directors for the fiscal year ending December 31, 2023). It contains detailed financial results for the year ended December 31, 2023, including the balance sheet, net profit, proposed dividend allocation, and extensive notes on financing activities and asset impairment tests. Although it frequently refers to the 'Rapport Annuel Intégré 2023 du Groupe UCB' for consolidated results and governance details, this specific document is the statutory annual report for the parent company (UCB SA) as presented to the shareholders for approval, which aligns perfectly with the definition of an Annual Report (10-K equivalent for non-US filers, or a comprehensive annual filing). Given the comprehensive nature and the year-end closing date, it is classified as an Annual Report. FY 2023
2024-03-22 French
Proxy General Meeting 25 April 2024 - NL - Final.pdf
AGM Information Classification · 99% confidence The document is titled "VOLMACHT VOOR DE ALGEMENE VERGADERING VAN AANDEELHOUDERS VAN 25 APRIL 2024" (Proxy for the General Meeting of Shareholders of April 25, 2024). It contains instructions on how to appoint a proxy holder and outlines the agenda items for the meeting, which include voting on the annual accounts, remuneration report, director appointments, and incentive plans. This document is a proxy form or related material used to solicit shareholder votes for an upcoming general meeting. This aligns directly with the definition of Proxy Solicitation & Information Statement (PSI). Although it mentions the Annual General Meeting (AGM-R), the document itself is the mechanism for voting/proxy submission, not the presentation materials (AGM-R) or the official voting results (DVA).
2024-03-22 Dutch
UCB-IAR2023-ENG.pdf
Annual Report Classification · 100% confidence The document is explicitly titled 'Integrated Annual Report 2023' and contains comprehensive sections including a letter to stakeholders, business performance reviews, corporate governance statements, remuneration reports, and consolidated financial statements with auditor reports. It meets the criteria for a full annual report (10-K equivalent for this jurisdiction) rather than a summary or announcement. FY 2023
2024-03-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.